Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | CEO & President, Director | $5.3M | +$1.06M | +24.9% | Dec 4, 2024 |
SGTX | Sigilon Therapeutics, Inc. | Director | Aug 11, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|